Teclison
Pre-clinicalTransforming cancer treatment by enhancing immunotherapy. At Teclison, we develop innovative cancer therapies to induce tumor necrosis and enhance antitumor immunity, offering patients with liver metastasis the hope of longer, better lives.
Founded
2015
Focus
Oncology
About
Transforming cancer treatment by enhancing immunotherapy. At Teclison, we develop innovative cancer therapies to induce tumor necrosis and enhance antitumor immunity, offering patients with liver metastasis the hope of longer, better lives.
Funding History
2Total raised: $12.5M
Series A$12MUndisclosedAug 15, 2022
Grant$500KNational Cancer InstituteMay 15, 2020
Company Info
TypePrivate
Founded2015
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile